75 related articles for article (PubMed ID: 16681747)
1. Acceptability of human immunodeficiency virus testing in patients with invasive cervical cancer in Kenya.
Gichangi P; Estambale B; Bwayo J; Rogo K; Ojwang S; Njuguna E; Temmerman M
Int J Gynecol Cancer; 2006; 16(2):681-5. PubMed ID: 16681747
[TBL] [Abstract][Full Text] [Related]
2. Attitudes to prenatal testing and notification for HIV infection in Nairobi, Kenya.
Marjan RS; Ruminjo JK
East Afr Med J; 1996 Oct; 73(10):665-9. PubMed ID: 8997847
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus seroprevalence in patients with invasive cervical cancer in Zaria, North-Western Nigeria.
Abdullahi A; Mustapha MI; David DA; Ayodeji OT
Ann Afr Med; 2018; 17(1):17-21. PubMed ID: 29363631
[TBL] [Abstract][Full Text] [Related]
4. Human African trypanosomiasis and human immunodeficiency virus co-infection in Western Kenya.
Matete GO; Kajejo OA
East Afr Med J; 2005 Jan; 82(1):20-3. PubMed ID: 16122107
[TBL] [Abstract][Full Text] [Related]
5. HIV infection among patients in U.S. acute care hospitals. Strategies for the counseling and testing of the hospital patients. The Hospital HIV Surveillance Group.
Janssen RS; St Louis ME; Satten GA; Critchley SE; Petersen LR; Stafford RS; Ward JW; Hanson DL; Olivo N; Schable CA
N Engl J Med; 1992 Aug; 327(7):445-52. PubMed ID: 1625734
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer incidence after up to 20 years of observation among women with HIV.
Massad LS; Hessol NA; Darragh TM; Minkoff H; Colie C; Wright RL; Cohen M; Seaberg EC
Int J Cancer; 2017 Oct; 141(8):1561-1565. PubMed ID: 28670714
[TBL] [Abstract][Full Text] [Related]
7. HIV and cervical cancer in Kenya.
Gichangi P; De Vuyst H; Estambale B; Rogo K; Bwayo J; Temmerman M
Int J Gynaecol Obstet; 2002 Jan; 76(1):55-63. PubMed ID: 11818095
[TBL] [Abstract][Full Text] [Related]
8. Impact of HIV infection on invasive cervical cancer in Kenyan women.
Gichangi PB; Bwayo J; Estambale B; De Vuyst H; Ojwang S; Rogo K; Abwao H; Temmerman M
AIDS; 2003 Sep; 17(13):1963-8. PubMed ID: 12960829
[TBL] [Abstract][Full Text] [Related]
9. CD4 T-LYMPHOCYTE SUBSETS IN WOMEN WITH INVASIVE CERVICAL CANCER IN KENYA.
Gichangi P; Gathece L; Estambale B; Temmerman M
East Afr Med J; 2013 Oct; 90(10):309-15. PubMed ID: 26862640
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya.
De Vuyst H; Gichangi P; Estambale B; Njuguna E; Franceschi S; Temmerman M
Int J Cancer; 2008 Jan; 122(1):244-6. PubMed ID: 17764116
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of human immunodeficiency virus-1 infection in a Baltimore acute care hospital.
Zuckerman CJ; Masters CF
Md Med J; 1993 Aug; 42(8):765-9. PubMed ID: 8412538
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Cervical Squamous Intraepithelial Lesions in HIV Infected Women in Kenya: a cross-Sectional Study.
Memiah P; Makokha V; Mbuthia W; Kiiru GW; Agbor S; Odhiambo F; Ojoo S; Mbizo J; Muhula S; Mahasi G; Biadgilign S
Afr J Reprod Health; 2015 Mar; 19(1):133-9. PubMed ID: 26103703
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus seroprevalence among cervical cancer patients.
Rogo KO; Kavoo-Linge
Gynecol Oncol; 1990 Apr; 37(1):87-92. PubMed ID: 2323619
[TBL] [Abstract][Full Text] [Related]
14. Serosurvey of human immunodeficiency virus infection in parturients. Implications for human immunodeficiency virus testing programs of pregnant women.
Landesman S; Minkoff H; Holman S; McCalla S; Sijin O
JAMA; 1987 Nov; 258(19):2701-3. PubMed ID: 3312662
[TBL] [Abstract][Full Text] [Related]
15. Demographic and AIDS-related characteristics of consenters to a population-based HIV-survey: results from a pilot study in Arusha, Tanzania.
Ole-King'Ori N; Klepp KI; Kissila PE; Biswalo PM; Mnyika KS
East Afr Med J; 1994 Aug; 71(8):483-9. PubMed ID: 7867536
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence study using oral rapid HIV testing in a large urban emergency department.
Jain S; Lowman ES; Kessler A; Harper J; Rumoro DP; Smith KY; Purim-Shem-Tov Y; Kessler HA
J Emerg Med; 2012 Nov; 43(5):e269-75. PubMed ID: 22541880
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with willingness to accept a routine offer of HIV test in a large referral hospital in Western Kenya.
Mangeni JN; Ballidawa JB; Ndege S
East Afr J Public Health; 2012 Mar; 9(1):44-9. PubMed ID: 23120949
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania.
Sweat M; Gregorich S; Sangiwa G; Furlonge C; Balmer D; Kamenga C; Grinstead O; Coates T
Lancet; 2000 Jul; 356(9224):113-21. PubMed ID: 10963247
[TBL] [Abstract][Full Text] [Related]
19. Does offering human immunodeficiency virus testing at the time of blood donation reduce transfusion transmission risk and increase disclosure counseling? Results of a randomized controlled trial, São Paulo, Brazil.
Goncalez TT; Blatyta PF; Santos FM; Montebello S; Esposti SP; Hangai FN; Salles NA; Mendrone A; Truong HM; Sabino EC; McFarland W
Transfusion; 2015 Jun; 55(6):1214-22. PubMed ID: 25646883
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus- 1 in leprosy patients attending Kenyatta National Hospital, Nairobi.
Munyao TM; Bwayo JJ; Owili DM; Ndinya-Achola JO; Kwasa TO; Kreiss JK
East Afr Med J; 1994 Aug; 71(8):490-2. PubMed ID: 7867537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
